Asha Kattige

Asha Kattige is a senior Regulatory Affairs professional with over 25 years of experience in the pharmaceutical and biotechnology sectors. They have held key roles including Principal Consultant at Scendea since 2022, where they provide technical advice in CMC, product development, and international regulatory affairs. Asha's previous positions include Associate Director at UCB, CMC Project Manager at Britannia, and Principal Formulation Scientist at Quotient Sciences. They also have experience as an Inhalation Formulation and Analytics Manager at Teva Pharmaceuticals and started their career as a Formulation Scientist at Patheon. Asha is currently pursuing a Doctor of Philosophy in Pharmaceutical Technology at the University of Sunderland.